The United States remains one of the largest and most attractive cosmetic markets in the world. For cosmetic manufacturers and brand owners looking to expand internationally, the opportunity is enormous. However, entering the US market requires a thorough understanding of USA cosmetic regulations, FDA requirements, product safety obligations, facility registrations, and the significant regulatory changes introduced by the Modernization of Cosmetics Regulation Act (MoCRA).
Many companies mistakenly assume that compliance with European cosmetic regulations automatically ensures compliance in the United States. In reality, while there are similarities, the US regulatory framework contains unique requirements that manufacturers, distributors, and responsible persons must address before placing products on the market.
The Regulatory Framework Governing Cosmetics in the USA
Cosmetics sold in the United States are primarily regulated by the US Food and Drug Administration (FDA). The main legal frameworks governing cosmetic products include:
- Federal Food, Drug and Cosmetic Act (FD&C Act)
- Fair Packaging and Labeling Act (FPLA)
- State-specific regulations such as California Proposition 65
- The Modernization of Cosmetics Regulation Act (MoCRA)
MoCRA represents the most significant reform of US cosmetic legislation since 1938 and has fundamentally changed compliance obligations for cosmetic companies operating in the American market.
For manufacturers exporting products to the USA, understanding these requirements is no longer optional—it is a crucial part of successful market access.
What Products Are Considered Cosmetics?
Under US legislation, cosmetics are products intended to be applied to the human body for cleansing, beautifying, enhancing attractiveness, or altering appearance. These include products such as:
- Facial skincare products
- Body care products
- Makeup
- Perfumes and fragrances
- Hair care products
- Personal hygiene products
However, classification becomes more complex when marketing claims enter the picture.
A cosmetic product can quickly become classified as a drug or medical device if claims suggest it can:
- Treat diseases
- Prevent medical conditions
- Alter bodily functions
- Influence physiological processes
This distinction is critical because drug products are subject to substantially stricter regulatory requirements than cosmetics.
MoCRA: The Biggest Regulatory Change in Decades
The introduction of MoCRA has transformed how cosmetic products are regulated in the United States.
The legislation introduced several entirely new obligations, including:
- Mandatory FDA facility registration
- Mandatory cosmetic product listing
- Good Manufacturing Practice compliance
- Safety substantiation requirements
- Adverse event reporting
- Mandatory recall authority for the FDA
- New fragrance allergen labelling obligations
- Responsible Person designation
- Enhanced record-keeping requirements
These requirements affect both domestic and international cosmetic manufacturers selling products in the USA.
For many companies, MoCRA has shifted cosmetic compliance from a relatively simple administrative process to a structured regulatory program requiring continuous maintenance and oversight.
The Role of the Responsible Person
One of the most important concepts introduced by MoCRA is the Responsible Person (RP).
The Responsible Person is generally the manufacturer, packer, or distributor whose name appears on the cosmetic product label.
The RP plays a central role in regulatory compliance and is responsible for:
- Product listings
- Safety substantiation records
- Adverse event management
- Communication with the FDA
- Compliance documentation maintenance
Every cosmetic product placed on the US market must have an identified Responsible Person who can demonstrate compliance when requested by regulatory authorities.
Product Listing Requirements
Cosmetic products marketed in the United States must be listed with the FDA through the Cosmetics Direct electronic portal.
The product listing process requires submission of information such as:
- Product identification details
- Responsible Person information
- Product categories
- Manufacturing details
- Ingredient-related information
Importantly, product listings are not a one-time activity. They must be maintained and updated regularly, with annual updates required under current requirements.
Failure to properly list products can lead to compliance risks and potential enforcement actions.
Facility Registration and the Importance of a US Agent
Manufacturing facilities that produce or process cosmetic products distributed within the United States must also register with the FDA.
This requirement applies to:
- US manufacturers
- Contract manufacturers
- Foreign cosmetic production facilities
For international companies, the process includes an additional requirement—the appointment of a US Agent.
The US Agent serves as the official communication point between the foreign manufacturer and the FDA, facilitating regulatory communication and assisting during inspections or inquiries.
Many international brands underestimate the importance of selecting a knowledgeable US Agent, but this role can become critical during regulatory reviews or compliance investigations.
Cosmetic Product Safety: The Manufacturer’s Responsibility
Unlike some regulatory systems where authorities approve products before market entry, the US cosmetic framework places primary responsibility for product safety on the manufacturer.
Under MoCRA, companies must maintain adequate safety substantiation demonstrating that products are safe under normal and reasonably foreseeable conditions of use.
Safety substantiation may include:
- Toxicological assessments
- Safety reports
- Scientific studies
- Ingredient evaluations
- Expert reviews
- Product testing data
The FDA does not prescribe a single mandatory testing protocol for every cosmetic product. Instead, manufacturers must determine which evidence is sufficient to support a reasonable certainty of safety.
This flexible approach provides opportunities but also creates responsibility for cosmetic companies to establish scientifically defensible safety programs.
Ingredient Compliance and Restricted Substances
Cosmetic products marketed in the USA must also comply with ingredient restrictions and color additive requirements.
Particular attention should be paid to:
- Color additives
- Talc-containing products
- PFAS substances
- Potential asbestos contamination
- State-specific ingredient restrictions
Color additives generally require FDA approval before use in cosmetic formulations, with limited exceptions. Failure to comply with color additive regulations may render products adulterated under US law.
As regulatory scrutiny increases, ingredient transparency and supplier verification have become increasingly important components of cosmetic compliance programs.
Good Manufacturing Practices (GMP)
Product quality begins long before a cosmetic reaches consumers.
MoCRA requires cosmetic manufacturers to comply with Good Manufacturing Practices (GMP), ensuring consistent production quality and product safety.
A robust GMP system typically includes:
- Controlled manufacturing procedures
- Staff training programs
- Documentation systems
- Quality control measures
- Supplier qualification processes
- Product traceability mechanisms
Strong GMP implementation not only supports compliance but also reduces business risks associated with recalls, complaints, and adverse events.
Cosmetic Labelling Requirements
Product labelling remains one of the most visible aspects of cosmetic compliance.
US cosmetic labels must provide accurate and non-misleading information while meeting all mandatory regulatory requirements.
Under MoCRA, additional labelling obligations include:
- Responsible Person contact details
- US address, telephone number, or electronic contact information
- Fragrance allergen declarations
- Professional-use statements where applicable
Incorrect, misleading, or incomplete labelling may cause products to be considered misbranded and subject to enforcement action.
For brands entering the US market, label reviews should always be conducted before products are launched.
FDA Enforcement Powers Have Expanded
One of the most significant consequences of MoCRA is the expansion of FDA enforcement authority.
The FDA now has greater powers to:
- Inspect safety documentation
- Review GMP compliance
- Request ingredient information
- Investigate adverse events
- Require voluntary recalls
- Mandate recalls when necessary
- Suspend facility registrations
These expanded powers reflect the FDA’s increasing focus on cosmetic product safety and regulatory accountability.
For manufacturers, this means that compliance should be viewed as an ongoing process rather than a one-time market entry exercise.
Why Professional Regulatory Support Matters
Navigating USA cosmetic regulations has become significantly more complex since the implementation of MoCRA.
Manufacturers must manage multiple compliance obligations simultaneously, including:
- Product classification
- FDA facility registration
- Product listing
- Responsible Person requirements
- Safety substantiation
- GMP compliance
- Labelling reviews
- Regulatory monitoring
A proactive regulatory strategy helps companies avoid costly delays, enforcement actions, product recalls, and market access issues.
At CE.way, we support cosmetic companies with regulatory compliance, product assessments, safety documentation, market access strategies, and ongoing regulatory support to help brands confidently enter and grow within the US cosmetics market.
